Clinical Trial Update: A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study) [NA]

View source ↗

Summary

A registry entry for the RESTORE-1 pilot study evaluating the safety, tolerability, and effectiveness of a radiofrequency vapor ablation system for proximal int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Aqua Medical, Inc. | Conditions: Type-2 Diabetes Mellitus | NA | Status: NOT_YET_RECRUITING